AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT02595554 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paclitaxel
Description: New adjuvant chemotherapy 3 cycles with Paclitaxel 150mg/m2 over 3 hours and Cisplatin
Study NCT00393458 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo to indacaterol
Description: Placebo to indacaterol was supplied in powder-filled capsules with a single-dose dry-powder inhaler (SDDPI).
Study NCT00393458 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo to formoterol
Description: Placebo to formoterol was supplied in powder-filled capsules with the manufacturer's proprietary inhalation device (Aerolizer®).
Study NCT00393458 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo to formoterol
Description: Placebo to formoterol was supplied in powder-filled capsules with the manufacturer's proprietary inhalation device (Aerolizer®).
Study NCT02119130 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: QGIT
Description: Seven pairs of clinics will be included in this study. One clinic in each pair will be selected by a computerized randomization program to be the standard of care arm (TST only) and the other will be in the QGIT arm.
Study NCT02367092 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise Program
Description: They will perform low-intensity, low-resistance exercise facilitated by a DVD video in their home. This exercise program lasts for 30 minutes at a time. Patients will be instructed to engage in this exercise program 3-4 times per week but not more often than 4 times per week. Pre-transplant patients will be asked to do the exercises from enrollment to transplant. Post-transplant patients will be asked to do the exercises for 6 months.
Study NCT01259739 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cocoa
Description: dissolved in water twice-daily intervention
Study NCT02024256 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Cold pads soaked in Magnesium sulfate solution
Study NCT02024256 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: Cold pads soaked in water
Study NCT02662439 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Body Composition Monitor (BCM)
Description: In the experimental group, the diuretic therapy adjusted according to the result of the BCM analysis.
Study NCT02662439 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Body Composition Monitor (BCM)
Description: In the experimental group, the diuretic therapy adjusted according to the result of the BCM analysis.
Study NCT01933984 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Bronchodilators inhalation
Description: Salmeterol/fluticasone (Seretide Evohaler) 4 puffs plus fenoterol (Berotec)(0.1mg/puff) 4 puffs inhalation when target airway resistance, measured every 8 hours, not met
Study NCT02595554 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Radical Surgery
Description: Radical hysterectomy (Type III or Type IV hysterectomy) plus bilateral pelvic lymph node dissection and para-aortic lymph node dissection or sampling
Study NCT01933984 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Bronchodilators inhalation
Description: Salmeterol/fluticasone (Seretide Evohaler) 4 puffs plus fenoterol (Berotec)(0.1mg/puff) 4 puffs inhalation when target airway resistance, measured every 8 hours, not met
Study NCT02897908 — intervention group
Intervention type: PROCEDURE
Intervention: vibration controlled transient elastography (VCTE)
Description: Once on the examination table, the subject will be instructed to place the right arm under their head and to cross their right ankle over the left ankle. The subject will then be asked to slightly bend to the left side to open the intercostal space. Subsequently, a handheld probe is placed in the intercostal space overlaying the right hepatic lobe. The velocity of returning shear waves, measured at a depth of 25-65 mm, is converted into a liver stiffness measurement (LSM). The LSM obtained from a given VCTE exam is the median value of at least 10 successful measurements. This information, along with clinical data associated with the patient will be placed in a database for use in identifying potential subjects for future trials.
Study NCT02433249 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: 1 Physical Activity
Description: Fall reducing strength (5), balance (12) and flexibility (4) exercises as well as walking. Participants were also given a Fitbit One with instructions on how to use
Study NCT02433249 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 1 Physical Activity
Description: Fall reducing strength (5), balance (12) and flexibility (4) exercises as well as walking. Participants were also given a Fitbit One with instructions on how to use
Study NCT02433249 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Interpersonal Motivation
Description: Strategies used to support Interpersonal motivational targets include: a) discuss and model ways to provide and receive more support for physical activity, b) identify environmental barriers to being physically active, c) problem-solve environmental and social barriers to being physically active, d) use and create new resources that support physical activity behavior
Study NCT02433249 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Intrapersonal Motivation
Description: Strategies used to support intrapersonal motivation included a) use of the goal attainment scale, b) facilitating the formation of action plans, c) identify and problem solve personal barriers to being active, d) identify satisfying aspects of being active, e) self-evaluate physical activity patterns and progress.
Study NCT02131701 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Physical activity
Study NCT02906046 — intervention group
Intervention type: DEVICE
Group type: OTHER
Intervention: Weight in Lower Limbs
Study NCT02906046 — intervention group
Intervention type: DEVICE
Group type: PLACEBO_COMPARATOR
Intervention: Weight in Lower Limbs
Study NCT01568762 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: VAK694
Description: Intravenous infusion
Study NCT01568762 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: VAK694 placebo
Description: Intravenous infusion
Study NCT01568762 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: QAX576
Description: Intravenous infusion
Study NCT01568762 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: QAX576 placebo
Description: Intravenous infusion
Study NCT02504333 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: nab-paclitaxel
Description: Day 1-8-15: Intravenous, 125 mg/m2 over 30 minutes
Study NCT02504333 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: gemcitabine
Description: Day 1-8-15: Intravenous, 1.000 mg/m2 over 30 minutes
Study NCT02504333 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: m-FOLFOX
Description: Day 28 according to the dose levels stablished in Phase I
Study NCT02504333 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: nab-paclitaxel
Description: Day 1-8-15: Intravenous 30 minutes according to the dose levels stablished in Phase I
Study NCT02504333 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: gemcitabine
Description: Day 1-8-15: Intravenous 30 minutes according to the dose levels stablished in Phase I
Study NCT03022786 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Order set
Description: Inpatient order set and ambulatory care guide offer guidance on initial compression to decrease edema, obtaining gradient compression stockings, how to access evaluation by vascular medicine for pain or dermatology for evaluation of allergic contact dermatitis if itch persists, etc
Study NCT04663919 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Bariatric surgery-RYGB
Description: After the creation of a 15-25-cc gastric pouch from the upper stomach, transection of proximal jejunum 70 cm from Treitz ligament also called alimentary tract and anastomosis of the distal end of jejunum to the gastric pouch, and thereafter, anastomosis of the proximal end of transected jejunum to the distal part of the jejunum at 150 cm below the site of transection (jejunoileal anastomosis).
Study NCT04663919 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Dietary intervention
Description: High-calorie medical nutrition program to ensure weight gain
Study NCT03034291 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Cacao 70%
Description: Consumption for 8 weeks of 50 grams of chocolate per day with 70% cocoa solids.
Study NCT03022786 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Motivational Interviewing training for home health aides
Description: Home Care aides trained about use of compression stockings and use of motivational interviewing as a tool to help patients make behavior changes to reduce leg swelling. This is part of our 'tool kit'.~There will be a focus group comprised of providers. This focus group will explore the perceptions of the providers and what unmet needs remain for the patients.
Study NCT03022786 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Tools & Education
Description: Engaged physical therapists to evaluate patients for ability to don stockings, to assess need for strengthening exercises or leg exercises to improve venous return. This is part of our 'tool kit'
Study NCT00350389 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Outdoor use of plain distance glasses with counselling
Description: Provision of single lens glasses, glasses aids, counselling, updated multifocal glasses if required
Study NCT04676503 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: BIOVAGINIL
Description: Biovaginil is a notified food supplement formulated as 480 mg capsules. Each capsule contains Lactobacillus crispatus NTCVAG04 3 billion and Vitamin A 120 μg.
Study NCT03676946 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ZKAB001 5mg/kg
Description: 5mg/kg/times bi-week IV administration of ZKAB001
Study NCT03676946 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ZKAB001 10mg/kg
Description: 10mg/kg/times bi-week IV administration of ZKAB001
Study NCT03676946 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ZKAB001 15mg/kg
Description: 15mg/kg/times bi-week IV administration of ZKAB001
Study NCT02365363 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Control
Description: Non pulse ingredient bagel
Study NCT02365363 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pea flour
Description: Pulse ingredient bagel
Study NCT02365363 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pea fibre
Description: Pulse ingredient bagel
Study NCT02365363 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pea flour and pea fibre
Description: Pulse ingredient bagel
Study NCT02365363 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pea flour and pea protein
Description: Pulse ingredient bagel
Study NCT02365363 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pea flour + pea fibre + pea protein
Description: Pulse ingredient bagel
Study NCT01197391 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: REGN728
Description: 2 Subcutaneous Cohorts (dose 1, 2)
Study NCT02595554 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: New adjuvant chemotherapy 3 cycles with Paclitaxel and Cisplatin 70mg/m2
Study NCT02521194 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Questionnaire
Description: Questionnaire completion regarding opinion of the inpatient occupational therapy session patient received.
Study NCT01248390 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Interactive metronome
Description: A randomized, controlled investigation into the effects of IM training on a sample of boys with attention deficit disorder showed positive results. Compared to an active control treatment, IM training improved performance on a host of measures, including attention, motor control, language processing, reading, and parental reports of improvements in the regulation of aggressive behavior.16 It should be noted that these cognitive and behavioral functions are common symptom areas in individuals surviving TBI and are likely to be especially affected in cases of blast injury
Study NCT01316900 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK573719/GW642444 125/25
Description: 125/25 mcg once-daily
Study NCT01316900 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GSK573719/GW642444 62.5/25
Description: 62.5/26 mcg once-daily
Study NCT01316900 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: GW642444
Description: 25 mcg once-daily
Study NCT01316900 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: tiotropium bromide
Description: 18 mcg once-daily
Study NCT04978831 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: PEP Device
Description: The breathing exercise device is a device that simulates pursed-lip breathing by creating positive expiratory pressure (PEP). Before starting to use the device, it will be explained that they need to put the mouthpiece on the device and put the nose clip on their nose, and the participants will be shown how it is done. The device will be used at 5 cmH2O pressure. A single exercise session consists of 3 exercise cycles, and a single exercise cycle consists of 15 breathing-exhalation activities. Participants will complete 3 cycles (a total of 45 inhales and exhales) in a single session. 1 loop lying on the left side, 1 loop lying on the right side, and 1 loop in sitting upright position. Participants held these sessions in the morning, afternoon, and evening. After completing each cycle, the participants will remove their nose clips and cough 2-3 times. Each participant will perform a total of 135 breathing exercises in one day.
Study NCT04978831 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Reading Aloud
Description: The patients in this group were given a book that they chose from among the book types within the scope of the study, according to their wishes. For the selection of books, opinions were taken from the experts in the education faculty of the same university and it was stated that any book separation was not important. The books that the participants wanted to read were provided by the researcher. They were asked to read this book aloud during the day, sitting upright on a chair or sofa, for 15 minutes, three times a day.~They were able to stop reading when the participant was tired or felt too short of breath to continue reading.
Study NCT03130322 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Imagery and Sleep questionnaires
Description: Participants complete a motor imagery questionnaire to assess their ability to form vivid mental images, as well as sleep questionnaires to control the quality of their sleep
Study NCT03130322 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MEG recordings (pre-test)
Description: Participants of the Day group perform two motor tasks (a finger sequential motor task and an adaptation motor task using a trackball) in the MEG, during a pre-test (Day 1 - 9h).~Task 1: Participants perform an 8-digit motor sequential task where each finger (except the thumb) is used twice. Performance is assessed by using a 4-keys keyboard. Participants are required to keep their fingers on the keys to minimize amplitude are instructed to tap the sequence as few errors as possible Task 2: Participants perform a motor adaptation task requiring scrolling a trackball to superimpose a geometric shape on another one, strictly similar but presented from another angle, as fast as possible.
Study NCT03130322 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Practice session
Description: Participants of the Day group perform a block of motor imagery practice of the two motor tasks.
Study NCT03130322 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MEG recordings (Post-test)
Description: Participants perform the two motor tasks in the MEG (post-test, strictly similar to the pre-test)
Study NCT03130322 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: MRI
Description: The registration of the brain anatomy of each participant will be done by MRI 3D / T the week before the first experimental session.
Study NCT03168997 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: Memantine Hydrochloride
Description: Memantine Hydrochloride treatment according to clinical routine treatment
Study NCT03682601 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 5% sinecatechins ointment
Description: Topical 5% sinecatechins ointment will be applied once daily.
Study NCT03682601 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Aquaphor/vehicle
Study NCT03682601 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 10% sinecatechins ointment
Description: Topical 10% sinecatechins ointment will be applied three times per week up to once daily.
Study NCT03874052 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Ruxolitinib
Description: Given PO
Study NCT03874052 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Venetoclax
Description: Given PO
Study NCT01065857 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Sodium picosulphate, light magnesium oxide and anhydride citric acid.
Description: 2 Single-dose sachets containing sodium picosulphate (0.01g/sachet), light magnesium oxide (3.50g/sachet) and anhydrous citric acid (10.97g/sachet).
Study NCT01065857 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Polyethylene glycol, KCl, NaCl, sodium sulphate anhydrous and sodium bicarbonate.
Description: 4 sachets containing Polyethylene glycol 3350 (59 gr), KCl (0.7425 gr), NaCl (1.465 gr), sodium sulphate anhydrous (5.685 gr), sodium bicarbonate (1.685 gr).
Study NCT04215718 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: fistulotomy and marsupialization
Description: the anal fistula was laid open and the the wound edges was marsupialized using vicryle 3\\0 sutures
Study NCT04215718 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: fistulectomy and wound closure
Description: anal fistula was excised with both openings and the wound was closed
Study NCT01304823 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: lactisole
Description: flavoring agent/sweet taste antagonist
Study NCT02050295 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Nerve block washout
Description: Saline will be infused through the perineural catheter to reverse motor block.
Study NCT02050295 — intervention group
Intervention type: PROCEDURE
Group type: SHAM_COMPARATOR
Intervention: Sham washout
Description: Infusion of saline to maintain catheter patency.
Study NCT04370249 — intervention group
Intervention type: OTHER
Intervention: pulmonary ultrasound
Description: pulmonary ultrasound on admission
Study NCT02050295 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Saline
Study NCT04557904 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Craniocervical flexion exercises
Description: Command the subject to be in crook lying position. Lock their finger to place their finger below the skull and retract the lower jaw and retract chin as far as possible. Subject has to slightly raise his/he skull a few centimeters. Fingers should be touching the cranium but not supporting it. Subject had to respire and hold the position. Subject has the move out the chin. Stop exercise and restart again. Perform this exercise for 10 times by holding this position for 20 sec at the start of the exercise, increasing it by 10 seconds every session commonly underwent pectoralis minor stretching before every session of exercise of 4 sets with 30 second's hold
Study NCT04557904 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Scapular stabilization exercises
Description: The scapular stabilization exercises were made up of four stages: (1) In supine position, the patient was commanded to deep respire for the sake of relaxation by maintain the cervical and shoulder in relaxing position to take a deep breath to relax the body while holding her shoulders and neck in relaxing position. (2) The patient then flex her knees and placed her feet flat on the plinth, and maintain the pose without any cervical movement. Then the patient asked to raise her dominant arm to 90° shoulder flexion with full elbow extension and scapular protraction. This position was sustained for 10 seconds before going to initial position. Three laps of 10 repetitions with one-minute interval in between were performed. (3) In quadruped position, the patient raise her arms alternatively with shoulder abduction and 120 ° flexion. That posture was held for 10 seconds before returning to the starting position. (4) In sitting position
Study NCT03309670 — intervention group
Intervention type: OTHER
Intervention: Psychiatric future
Description: Former young psychiatric patients are contacted to determine their psychiatric outcome.
Study NCT03746197 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Project EVO Multi- Treatment
Description: The EVO platform assesses perceptual discrimination while single-and multi-tasking. Visuomotor tracking involves navigating a character through a dynamically moving environment while avoiding obstacles. EVO uses adaptive algorithms to change game difficulty on a trial by trial and patient by patient basis for the tracking task and discrimination task with real-time feedback.
Study NCT01828827 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PA-824 1000 mg
Description: Two single administrations of 1000mg each administered by 5 tablets of 200mg, one administered in the fed state and one administered in the fasted state.
Study NCT02050295 — intervention group
Intervention type: DRUG
Group type: SHAM_COMPARATOR
Intervention: Saline